Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novocure Ltd Ord Sh (NQ: NVCR )

17.73 +0.64 (+3.74%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novocure Ltd Ord Sh

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Where NovoCure Stands With Analysts
NovoCure (NASDAQ:NVCR) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2022
Upgrades According to Consumer Edge Research, the prior rating for The Hain Celestial Group Inc (NASDAQ:HAIN) was changed from Equal-Weight to Overweight. For the second... 
Via Benzinga
World Markets News
Today oil and gas inventories were seen as higher than expected while potential prices fell, both bullish. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09... 
Via Benzinga
Cramer Gives His Opinion On Novocure, InMode, Virgin Galactic And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Atkore (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022
Upgrades For W.P. Carey Inc (NYSE:WPC), B... 
Via Benzinga
Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer
Pfizer and Bayer inked deals with several companies in gene-editing. 
Via Investor's Business Daily
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
From Novocure
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a... 
Via Benzinga
Novocure to Participate in the 40th Annual J.P. Morgan Healthcare Conference
From Novocure
Via Business Wire
Start Of 2022
Mohammed El Erien predicts that the Fed will be slamming on the brakes this year. 
Via Talk Markets
Happy New Year - Sunday Edition
Starting a new year - we look at tech, pharma and mining stocks and their goings-on. 
Via Talk Markets
Market Trend: Erratic And Unreliable
Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is. 
Via Talk Markets
Stocks Hitting New 52-Week Lows Today
On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was... 
Via Benzinga
Plague Year Reversal
Just in time for Christmas, the market decided to go up today pretty much across the board. 
Via Talk Markets
Inflation Surge
Today the market failed to brush off inflation fears as it had done later on Thursday as inflation is at a 4 decade high. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
Upgrades For nVent Electric PLC (NYSE:NVT), Vertica... 
Via Benzinga
Novocure Signs Agreement to Acquire and Construct Building in Downtown Portsmouth, New Hampshire
From Novocure
Via Business Wire
recession in 2022?
China has cut its reserve requirement for lending by 50% giving a $188 bn boost to its market. 
Via Talk Markets
Topics Economy
Exposures Economy
Novocure Announces 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
From Novocure
Via Business Wire
Charms Of China
Today the global stock market rout was pretty awful. 
Via Talk Markets
Is It Time to Buy the 3 Worst-Performing Growth Stocks of 2021?
This year's big pullbacks are more the result of a raucous 2020, and less an indictment of these companies' prospects. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Tuesday Markets Review
The oil price did not fall as expected over the White House release of 50 mn bbls of oil. 
Via Talk Markets
Tuesday Markets Coverage
GE was up on hopes for cheaper oil. But most stocks were down on oil price hike fears. 
Via Talk Markets
Novocure to Participate in Two Upcoming Investor Conferences
From Novocure
Via Business Wire
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-small Cell Lung Cancer
From Novocure
Via Business Wire
Novocure Posts Data For Tumor Treating Fields In Brain Tumor Trial
Novocure Ltd (NASDAQ: NVCR) has released updated data from the Phase 2 pilot 2-THE-TOP of Tumor Treating Fields (TTFields) together with pembrolizumab and... 
Via Benzinga
2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma
From Novocure
Via Business Wire
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback